|
|
|
GTCbio, San Diego
2012-03-09
GTC is proud to present the Antibody Design and Discovery Conference on June 7-8, 2012 at the Hilton San Diego Resort & Spa in San Diego, CA! At the Antibody Design and Discovery Conference, leading industry and academic innovators will discuss exciting clinical trends and applications of antibodies. We’ll explore novel technologies being utilized to identify and select antibodies with better accuracy and efficiency, and learn about new optimization and developability techniques to enhance effective function. Moreover, attendees will hear directly from scientists and researchers about emerging clinical data, and its implications for the advancement of the field, including therapeutic antibodies in cancer, and infectious and autoimmune diseases. Session Topics Improving Antibody Discovery and Selection Techniques Novel Sequencing Techniques, Computational Discovery Library Characterization In Vitro Discovery & Selection Optimization Strategies: Enhancing Effective Function Epitope Mapping, Increasing Antigen Binding & Affinity Purification Systems Small Particles & Fragments, Solubility Antibody Drug Conjugates Bispecific/ Bifunctional Antibodies, Multispecific Antibodies Fc Engineering, Half Life Enhancement Recombinant Antibodies, Fusions Biosimilar Design and Efficacy Novel Advances in Therapeutic Antibodies Developability in the areas of Cancer, Infectious Diseases, Autoimmune Diseases This conference is also part of the Drug Discovery and Regulatory Summit, which consists of this track and three other tracks: Biospecimens and Biorepositories 6th Drug Design and Medicinal Chemistry Life Science Legal & Business Strategy Conference Date: June 7-8, 2012 Venue: San Diego , CA, USA 1775 East Mission Bay Drive | San Diego, CA 92109 Event Link: http://www.gtcbio.com/index.php?option=com_conference&file=home&cn=Antibody%20Design%20and%20Discovery&cid=84
|
|
|
|
|
|
Organized by:
|
|
GTCbio |
|
Invited Speakers:
|
|
DISTINGUISHED SPEAKERS Javier Chaparro- Riggers, Principle Scientist, Protein Engineering, Rinat Laboratories, Pfizer GRD
Ho Sung Cho, Chief Technology Officer, Ambrx
Dimiter Dimitrov, Senior Investigator, Head, Protein Interaction Group, NCI, NIH
William Finlay, Director, Protein Discovery and Optimization, BioTx, Pfizer WRD
Jacob Glanville, Principle Scientist, Protein Generation Unit, Rinat Laboratories, Pfizer GRD
Jacquelyn Hank, Research Professor, Human Oncology, University of Wisconsin
Brantley Herrin, Assistant Professor, Pathology and Laboratory Medicine, Emory University
David Hilbert, Chief Scientific Officer, Head of Research and Development, Zyngenia
Azad Kaushik, Associate Professor, Immunology, University of Guelph
David King, Chief Scientific Officer, AnaptysBio
Olivier Laurent, Director, Protein Science, CovX Research, Pfizer WRD
Benfang Lei, Assistant Professor, Veterinary Molecular Biology, Montana State University
Nancy Levin, Director, Biology, CovX Research, Pfizer WRD
Giovanni Magistrelli, Head, Protein Generation Unit, Novimmune
John Mascola, Deputy Director, Vaccines Research Center, NIAID, NIH
David Meininger, Senior Director, Biologics Discovery, Merck
Jim Mo, Research Fellow, Pfizer
Robert Rush, Emeritus Professor, Human Physiology, Flinders University
William Schief, Associate Professor, Immunology and Microbial Science, The Scripps Research Institute
Jan Schnitzer, Director, Professor, Cellular and Molecular Biology, Proteogenomics Research Institute for Systems Medicine (PRISM)
Vaughn Smider, Assistant Professor, Molecular Biology, The Scripps Research Institute
Charles Theuer, President, Chief Executive Officer, TRACON Pharma
Mohit Trikha, Chief Scientific Officer, Vice President, Early Development, Triphase Accelerator
Edmond Yunis, Professor, Pathology; Chief, Immunogenetics, Harvard Medical School; Dana-Farber Cancer Institute
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2012-06-08
|
|
|
|
|
|
Registration:
|
|
https://www.gtcbio.com/index.php?option=com_register&cn=Antibody%20Design%20and%20Discovery&cid=84
|
|
E-mail:
|
|
ken.lin@gtcbio.com
|
|
|
|
|
|
|
|